Kymera Therapeutics, Inc.

Ownership Transactions Reported by 22 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	2	+4.35M	75.1%	$34.59	+$150M
Sells	8	-1.44M	24.9%	$40.34	-$58.2M
Net	-6	+2.9M	50.1%		+$92.1M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Baker Bros. Advisors Lp	Director	$648M	+$106M	+19.5%	Aug 20, 2024
Atlas Venture Fund X, L.P.	10%+ Owner	$236M	-$14.9M	-5.95%	Mar 11, 2024
Atlas Venture Associates X, L.P.	10%+ Owner	$173M			Aug 11, 2021
Bruce Booth	Director	$28.4M	-$38.3M	-57.5%	Jul 9, 2024
Nello Mainolfi	Chief Executive Officer, Director	$22.7M			Jul 1, 2024
Bvf Partners L P/Il	Director, Other*	$20.1M	+$44.6M		Aug 20, 2024
Bruce N. Jacobs	Chief Financial Officer	$5.9M	-$165K	-2.72%	Jun 27, 2024
Jared Gollob	Chief Medical Officer	$4.4M	-$3.6M	-45%	Jul 15, 2024
Ellen Chiniara	Chief Legal Officer	$2.42M	-$74.4K	-2.98%	Mar 1, 2024
Jeremy G. Chadwick	Chief Operating Officer	$1.55M	-$90.1K	-5.51%	May 23, 2024
Elaine Caughey	Chief Business Officer	$570K			Mar 1, 2023
Joanna Horobin	Director	$0	-$280K	-100%	Jun 7, 2024
Jeffrey W. Albers	Director	$0	-$741K	-100%	Aug 26, 2024
Richard Chesworth	Chief Scientific Officer				Aug 27, 2021
Steven Edward Hall	Director				Jun 16, 2021
Victor Sandor	Director				Jun 18, 2024
Gorjan Hrustanovic	Director				Jun 18, 2024
Donald William Nicholson	Director				Jun 15, 2022
Elena Ridloff	Director				Jun 18, 2024
Leigh Morgan	Director				Jun 18, 2024
Pamela Esposito	Director				Jun 18, 2024
John Maraganore	Director				Jun 18, 2024

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.